Chemical Component Summary

Name2-methyl-1-[2-(propan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]propan-1-one
Identifiers2-methyl-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one
FormulaC14 H18 N2 O
Molecular Weight230.31
TypeNON-POLYMER
Isomeric SMILESCC(C)c1c(c2ccccn2n1)C(=O)C(C)C
InChIInChI=1S/C14H18N2O/c1-9(2)13-12(14(17)10(3)4)11-7-5-6-8-16(11)15-13/h5-10H,1-4H3
InChIKeyZJVFLBOZORBYFE-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count35
Chiral Atom Count0
Bond Count36
Aromatic Bond Count10

Drug Info: DrugBank

DrugBank IDDB05266 
NameIbudilast
Groupsinvestigational
DescriptionIbudilast is an anti-inflammatory and neuroprotective oral agent which shows an excellent safety profile at 60 mg/day and provides significantly prolonged time-to-first relapse and attenuated brain volume shrinkage in patients with relapsing-remitting (RR) and/or secondary progressive (SP) multiple sclerosis (MS). Ibudilast is currently in development in the U.S. (codes: AV-411 or MN-166), but is approved for use as an antiinflammatory in Japan.
Synonyms
  • Ibudilastum
  • Ibudilast
IndicationFor the treatment of multiple sclerosis, asthma, and cerebrovascular disease.
Categories
  • Anti-Asthmatic Agents
  • Antiplatelet agents
  • Autonomic Agents
  • Bronchodilator Agents
  • Cardiovascular Agents
ATC-CodeR03DC04
CAS number50847-11-5

Drug Targets

NameTarget SequencePharmacological ActionActions
cAMP-specific 3',5'-cyclic phosphodiesterase 4AMEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSD...unknowninhibitor
cAMP-specific 3',5'-cyclic phosphodiesterase 4BMKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNL...unknowninhibitor
cAMP-specific 3',5'-cyclic phosphodiesterase 4CMENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDP...unknowninhibitor
cAMP-specific 3',5'-cyclic phosphodiesterase 4DMEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRL...unknowninhibitor
cGMP-inhibited 3',5'-cyclic phosphodiesterase AMAVPGDAARVRDKPVHSGVSQAPTAGRDCHHRADPASPRDSGCRGCWGDL...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem3671
ChEBICHEBI:31684
ChEMBLCHEMBL19449
PharosCHEMBL19449